I haven't decided what to think about the controversial "Frankenfish," the genetically modified salmon whose maker, Massachusetts-based AquaBounty Technologies, is seeking Food and Drug Administration (FDA) approval — and seems positioned to get it. Starting Sunday, Sept. 19, an FDA advisory panel will convene a two-day public hearing on the matter.
More
Read More